PR001111 (Project)

Description:Application of 1H HRMAS NMR Spectroscopy to study malignancy induced metabolomic changes in urinary bladder tissues from 26 NMIBC patients. Predict the possible biomarker of NMIBC in urinary bladder tissues.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR001111 project

File

A 804 KB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project

File

A 2.78 MB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project

File

A 697 KB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project

Biosample

A biosample from Metabolomics produced as part of the PR001111 project

Biosample

A biosample from Metabolomics produced as part of the PR001111 project

Biosample

A biosample from Metabolomics produced as part of the PR001111 project

Biosample

A biosample from Metabolomics produced as part of the PR001111 project

Biosample

A biosample from Metabolomics produced as part of the PR001111 project


  • Subject

    A subject from Metabolomics produced as part of the PR001111 project


  • File

    A 804 KB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project


  • File

    A 2.78 MB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project


  • File

    A 697 KB file from Metabolomics produced from OBI:0000623 as part of the PR001111 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001111 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001111 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001111 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001111 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001111 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.